<p>The present invention provides antibodies directed against C-terminal and central epitopes of Abeta that preferentially bind compact plaques relative to diffuse plaques. The invention also provides methods of treating patients to reduce or eliminate the presence of compact plaques of Abeta and associated symptoms.</p>
